SCHEMBL5645847

SCHEMBL5645847

Cc1cccc(C2(c3nc(-c4ccncc4)cs3)CC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.52
KMT2A Q03164 4/20 0.52
MAPT P10636 4/20 0.52
MEN1 O00255 3/20 0.52
MAPK1 P28482 3/20 0.52
HTT P42858 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
ROCK2 O75116 1/20 0.45
ROCK1 Q13464 1/20 0.45
ELOVL1 Q9BW60 1/20 0.44
NPC1 O15118 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 2/20 0.43
LTA4H P09960 1/20 0.40
AR P10275 1/20 0.39
CYP19A1 P11511 1/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5646704 0.84 ROCK1 (0.45) RAB9AKMT2AMAPTMEN1MAPK1
SCHEMBL12487245 0.83 ELOVL1 (0.55) RAB9AKMT2AMAPTMEN1MAPK1
SCHEMBL5648655 0.81 LTA4H (0.43) RAB9AKMT2AMAPTMEN1MAPK1
SCHEMBL5648038 0.77 KMT2A (0.43) RAB9AKMT2AMAPTMEN1MAPK1
SCHEMBL5645472 0.77 RAB9A (0.54) RAB9AKMT2AMAPTMEN1MAPK1
SCHEMBL5645955 0.77 RAB9A (0.54) RAB9AKMT2AMAPTMEN1MAPK1
SCHEMBL5645540 0.77 KDM4E (0.43) RAB9AKMT2AMAPTMEN1MAPK1
SCHEMBL5643715 0.77 AR (0.54) RAB9AKMT2AMAPTHTTROCK2
SCHEMBL14367714 0.75 ALDH1A1 (0.50) RAB9AKMT2AMAPTMEN1ELOVL1
SCHEMBL5646967 0.75 KDM4E (0.44) RAB9AKMT2AMAPTMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7294640-B2 Mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-11-13 US claimed
US-20050176776-A1 kINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUORPHENYL)-N-3-FLUOROPYRROLIDIN-3-YL)-2-HYDROXYMETHYL-2-PHENYL-2,5 -DIHYDROXY-1N-PYRROL-1-CARBOXAMIDE MERCK SHARP & DOHME CORP. 2005-08-11 US claimed
US-7294640-B2 Mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-11-13 US disclosed
US-7294640-B2 Mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-11-13 US disclosed
US-7294640-B2 Mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-11-13 US disclosed
US-20050176776-A1 kINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUORPHENYL)-N-3-FLUOROPYRROLIDIN-3-YL)-2-HYDROXYMETHYL-2-PHENYL-2,5 -DIHYDROXY-1N-PYRROL-1-CARBOXAMIDE MERCK SHARP & DOHME CORP. 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176776-A1 kINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUORPHENYL)-N-3-FLUOROPYRROLIDIN-3-YL)-2-HYDROXYMETHYL-2-PHENYL-2,5 -DIHYDROXY-1N-PYRROL-1-CARBOXAMIDE KIF5B, KIF2C, KIFC1 RAB9A 2496/4885KMT2A 1097/4885MAPT 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.